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Extended Followup of a Cohort of
Chromium Production Workers
Herman Jones Gibb, PhD,1 Peter St. John Lees, PhD,2 Jing Wang, M.S.,3 and
Keri Grace O’Leary, M.S.1,4
Background The current study evaluates the mortality of 2,354 workers first employed at
a Baltimore chromate production plant between 1950 and 1974.
Methods The National Death Index (NDI Plus) was used to determine vital status and
cause of death. Cumulative chromium (VI) exposure and nasal and skin irritation were
evaluated as risk factors for lung cancer mortality.
Results There are 91,186 person-years of observation and 217 lung cancer deaths.
Cumulative chromium (VI) exposure, nasal irritation, nasal perforation, nasal ulceration,
and other forms of irritation (e.g., skin irritation)were associatedwith lung cancermortality.
Conclusion Cumulative chromium (VI) exposure was a risk factor for lung cancer death.
Cancer deaths, other than lung cancer, were not significantly elevated. Irritation may be a
possible mechanism for chromium (VI)-induced lung cancer. Am. J. Ind. Med. 58:905–
913, 2015. © 2015 The Authors. American Journal of Industrial Medicine Published by
Wiley Periodicals, Inc.
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INTRODUCTION
In the middle of the 20th century, several studies
identified an increased lung cancer risk among workers in the
chromate-producing industry in the United States [Machle
and Gregorius, 1948; Baetjer, 1950; Mancuso and Hueper,
1951; U.S. Public Health Service, 1951]. Since that time
additional studies have added to the strength of evidence
of the carcinogenicity of chromium (VI). IARC [1990]
concluded that there is sufficient evidence in humans for the
carcinogenicity of chromium (VI) compounds as encoun-
tered in the chromate production, chromate pigment
production and chromium plating industries. In its most
recent evaluation of chromium VI compounds, IARC [2012]
concluded that there is sufficient evidence in humans of the
carcinogenicity of chromium (VI) compounds. IARC [2012]
also concluded that chromium (VI) compounds cause cancer
of the lung and that positive associations have been observed
between exposure to chromium (VI) compounds and cancer
of the nose and nasal sinuses.
Park et al. [2004], using the data from Gibb et al.
[2000a], estimated the excess lifetime risk for various
concentrations of chromium (VI) assuming a 45-year
exposure. Park et al. [2004] is the basis of the National
Institute of Occupational Safety and Health (NIOSH)
Recommended Exposure Limit (REL) for chromium (VI).
WHO [2013] used the Park et al. [2004] estimates as the basis
of its lifetime lung cancer risk estimates for occupational and
environmental exposure to chromium (VI).
The current study is an update of the cohort study by
Gibb et al. [2000a] of workers employed at a chromate
production plant in Baltimore. Gibb et al. [2000a] is an
extension ofHayes et al. [1979].Hayes et al. [1979] identified
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4,217 workers at the Baltimore facility who were newly
employed between January 1, 1945 and December 31, 1974
and excluded workers employed fewer than 90 days, women,
and those with unknown length of employment. This resulted
in a cohort of 1,803 hourly employees and 298 salaried
employees. The authors found that the risk of lung cancer
increased with duration of employment but did not have the
data to quantitatively evaluate chromium (VI) concentrations
and lung cancer risk.
Gibb et al. [2000a] obtained measures of airborne
chromium (VI) concentrations for the Baltimore facility
from company records. The Gibb et al. [2000a] cohort is
similar to the Hayes et al. [1979] cohort, but Gibb et al.
[2000a] excluded those who began work before August 1,
1950 (n¼ 734). On that date the construction of a new mill
and roast plant was completed, and extensive exposure
information was collected from that date forward. Gibb et al.
[2000a] included workers who worked fewer than 90 days
but began employment after August 1, 1950 (n¼ 990) to
expand the size of the low cumulative exposure group. The
resulting cohort size was 2,357. Exposure work histories in
Gibb et al. [2000a] were updated through July 1985, the date
when operations at the plant ceased. Smoking status at the
beginning of employment and clinical findings of irritation
were identified from companymedical records. The resulting
study had 70,736 person-years of observation and 855 deaths
including 122 lung cancer deaths. The authors found that
lung cancer risk increased with cumulative chromium (VI)
exposure and was not confounded by smoking status. There
was no evidence of an increased lung cancer risk with
cumulative chromium (III) exposure.
The current study was undertaken to evaluate how the
lung cancer risk observed in Gibb et al. [2000a] may have
changed over the course of the additional 19-year follow-up
period and provide additional detail to that presented in the
original study. Specifically, the aims of the current study
were to (i) evaluate whether an interaction exists between
smoking and chromium (VI), (ii) explore the relationship
between clinical irritation and lung cancer risk, (iii)
determine whether mortality from diseases other than lung
cancer is elevated, and (iv) evaluate whether an increased
lung cancer risk exists at lower cumulative exposures than
those found in Gibb et al. [2000a].
METHODS
The Institutional Review Board approval for this study
was granted by the Johns Hopkins Bloomberg School of
Public Health Institutional Review Board (FWA#0000287).
Smoking status at hire (yes/no) was recorded from
company records. Clinical findings of irritation were based
on records from the dispensary, physical examination, and
hospital, and in the case of perforated septum, compensation
reports. Signs of irritation included irritated nasal septum,
ulcerated nasal septum, perforated nasal septum, bleeding
nasal septum, irritated skin, ulcerated skin, dermatitis, burn,
conjunctivitis, and perforated eardrum. Estimates of expo-
sure to chromium (VI) (CrO3) were assigned by job title and
based on approximately 70,000 contemporary measurements
of airborne chromium (VI) concentration spanning the
period of August 1, 1950, the date of first employment,
through July 1985, the date that operations at the plant
ceased. These exposure estimates were merged with each
study member’s work history to provide a profile of annual
average exposures throughout their period of employment at
the chromate production facility. Chromium (III) exposure
was estimated based on the ratio of chromium (VI) to
chromium (III) in settled dust. Further detail on the exposure
assessment methods is available in Gibb et al. [2000a]. For
the current study, the National Death Index (NDI Plus) was
used to identify deaths occurring between January 1, 1993
and December 31, 2011. NDI Plus reports causes of death by
the International Classification of Diseases codes 8th, 9th, or
10th revisions depending on the date of the death [National
Center for Health Statistics, 2013].
The National Institute for Occupational Safety and
Health (NIOSH) Life Table Analysis System (LTAS)Version
3.0.3 Build 7 was used to develop O/E ratios and confidence
intervals for deaths from different causes [NIOSH, 2013a].
LTAS calculates age-, race-, sex-, and calendar time-adjusted
standardized mortality ratios. We used national cause-
specific reference data (92 underlying causes of death for
the period 1940–2007) for the analysis of deaths by all
causes. This rate file is based on United States mortality rates
stratified by gender, race, and 5-year calendar time period.
Underlying cause of death is defined as the disease or injury
that initiated the sequence of events leading directly to death.
LTAS estimates national and Maryland rates for 2008–2011
based on the rates for 2005–2007. Expected deaths for those
with race unknown assumed a race distribution similar to the
rest of the cohort.
Approximately 61% of all deaths occurred in Maryland;
thus, Maryland rates in LTAS (119 causes of death for the
period 1960–2007) were used to calculate expected lung
cancer deaths. After receipt of the NDI Plus update, it was
discovered that 12 workers, if alive, would be older than
100 years and 46 workers, if alive, would be older than
96 years. These individuals were likely lost to follow-up. The
oldest age of death in the cohortwas 96. Thus itwas decided to
consider the end of follow-up as December 31, 2011 or age 96
if the birthdate indicated the individual was beyond the age of
96. One lung cancer death occurred in July 1959; another
occurred in November 1959. Because the LTAS rate file for
Maryland for 119 causes of death doesn’t recognize deaths
occurring before 1960, the dates of the two deaths were
changed to January 1, 1960 for the analysis. Confidence
intervals for the O/E lung cancer deaths were produced using
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Fisher’s exact test [Rothman and Boice, 1979]. Trend for O/E
lung cancer death was evaluated using the method of Breslow
et al. [1983]. Trend for odds ratios (ORs) of lung cancer death
bynumber of nasal irritations per individualwere evaluatedby
the method of Cochran and Armitage [Cochran, 1954;
Armitage, 1955]. Wald confidence limits for the ORs of
lung cancer death by number of nasal irritations per individual
were estimated using SAS version 9.2 [SAS, 2009]. SAS
version 9.2 was also used to produce frequency data, mean
exposure for the observed-to-expected (O/E) ratios, means
and medians of the exposure quartiles, and proportional
hazards and logistic regression models [SAS, 2009].
The association of lung cancer with 10 different clinical
findings of chromium irritation was examined using logistic
regression. Lung cancer risk was also evaluated by frequency
of different signs of nasal irritation (irritated nasal septum,
ulcerated nasal septum, perforated nasal septum, bleeding
nasal septum) per individual.
A proportional hazards model using age as the time
variable and cumulative exposure as a time-varying
covariate was used to assess the relationship of chromium
exposure and lung cancer risk. The effects of log
transformation and different lag periods on the analysis
were evaluated. Log transformation of cumulative chromium
(VI) and chromium (III) exposures was found to improve the
fit of the proportional hazard models (smaller Akaike
information criterion) [Akaike, 1973]. The fit for a five
year lag was similar to the fit for a zero year and a ten year
lag. A five year lag was chosen.
The cohort of Gibb et al. [2000a] included 2,357
individuals. It was discovered in the current update that one
of the 2,357 was female and two individuals had the same
birth dates, dates of first employment and dates of
termination but had different exposure profiles. It was
decided to eliminate these three individuals from further
analysis resulting in a cohort size of 2,354.
RESULTS
Therewas a total of 1,613 deaths from all causes (69%of
cohort), 217 lung cancer deaths (9.2% of cohort), and 91,186
person-years of observation (follow-up to December 31,
2011 or age 96) in the current update. A summary of causes
of death for the current update is reported in Table I.
Lung cancer mortality for the total cohort was
significantly elevated (O/E¼ 1.63, 95% CI: 1.42, 1.86).
Death from alcoholism (O/E¼ 2.50, 95%CI: 1.58, 3.75) and
other accidents (O/E¼ 1.97, 95% CI: 1.46, 2.60) were also
significantly elevated. Significantly fewer deaths than
expected were found for kidney cancer, nervous system
disorders and cerebrovascular disease.
Table II provides a description of the entire cohort, the
lung cancer cases, and the non-lung cancer cases by selected
continuous exposure-related variables. The length of time
from the date of first employment until the date of lung
cancer death ranged from 6.4 years to 57.2 years with a mean
of 33.8 (SD¼ 10.7) years. Figure 1 is a distribution of the
time from date of hire until date of death for the 217 lung
cancer deaths.
There was a high proportion of cigarette smokers and
“any smoking” (includes cigarettes, cigars, and pipes) in the
cohort. Eighty, 79, and 65 percent of whites, nonwhites, and
race unknown, respectively, were smokers. The vast majority
(93%) of lung cancer deaths occurred among cigarette
smokers (n¼ 202) vs. 2% among nonsmokers (n¼ 4), and
11 (5%) among individuals whose smoking status was
unknown.
Table III allows an examination of the effect of age and
cumulative chromium (VI) exposure on lung cancer
mortality. Table IV is an examination of lung cancer O/E
ratios by race (white, nonwhite) for the four cumulative
chromium (VI) exposure quartiles. For the total cohort (all
races combined including unknown race), there was an
increase in the O/E lung cancer ratios from the first to the
second quartile, a leveling off between the second and third
quartiles, and an increase from the third to the fourth quartile.
The trend is statistically significant (P< 0.001).
In a mortality analysis limited to smokers, the O/E for
lung cancer became more pronounced within each exposure
quartile, and the exposure-response for the total group was
monotonic: First Quartile O/E¼ 1.18 (95% CI 0.84–1.60);
Second Quartile O/E¼ 1.81 (95% CI 1.34–2.39); Third
Quartile O/E¼ 1.95 (95%CI 1.44–2.58); Fourth Quartile O/
E¼ 2.54 (95% CI 1.96–3.24).
Cumulative chromium (VI) exposure was a significant
(P> 0.05) predictor of lung cancer when included in a model
with smoking and years worked. When cumulative chromi-
um (VI) exposure and cumulative chromium (III) exposure
were included in a model with smoking, neither was
statistically significant (P> 0.05), but the parameter estimate
for cumulative chromium (III) exposure was negative. The
log cumulative chromium (VI) exposure and log cumulative
chromium (III) exposure are strongly correlated (Pearson
correlation coefficient¼ 0.98, P< 0.001). In a proportional
hazards model with smoking, each unit increase in log10
cumulative chromium (VI) exposure was associated with a
1.255-fold (P< 0.001) increase in the risk of lung cancer
mortality. Smoking was associated with a 13.498-fold
(P< 0.001) increase in risk.
Slightly over 80% of the cohort experienced at least one
sign of nasal irritation. Among lung cancer cases, 84.8%
experienced at least one sign of nasal irritation; among non-
lung cancer cases 79.8% experienced at least one sign of nasal
irritation. The percentage of lung cancer cases that experi-
enced one ormore signs of irritation was 87.6%, while among
non-cancer cases it was 83.0%. A significant association
(P> 0.05) of lung cancerwith the occurrence of irritated nasal
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TABLE I. Observed/Expected Ratios for Selected Causes of Death
a,b
of Chromium ProductionWorkersc,Baltimore,MD,1950^2011
Cause of Death Observed Expected SMR (O/E) 95% CI
All Causes 1613 1501.14 1.07 1.02^1.13
All Cancers 460 395.32 1.16 1.06^1.27
Buccal & pharynx cancer 12 9.71 1.24 0.64^2.16
Pharynx 9 5.12 1.76 0.80^3.34
Digestive & peritoneum cancer 90 100.54 0.90 0.72^1.10
Esophagus 18 14.12 1.28 0.76^2.02
Stomach 7 14.56 0.48 0.19^0.99
Intestine 32 32.20 0.99 0.68^1.40
Rectum 7 6.74 1.04 0.42^2.14
Biliary, liver, gall bladder 14 12.00 1.17 0.64^1.96
Pancreas 12 19.65 0.61 0.32^1.07
Respiratory System Cancer 229 139.39 1.64 1.44^1.87
Larynx 10 5.30 1.89 0.90^3.47
Trachea, bronchus & lung 217 133.01 1.63 1.42^1.86
Male genital cancer 36 45.81 0.79 0.55^1.09
Prostate 36 44.84 0.80 0.56^1.11
Urinary cancer 13 18.63 0.70 0.37^1.19
Bladder & other urinary 10 9.79 1.02 0.49^1.88
Other & unspecified site cancers 53 45.76 1.16 0.87^1.52
Skin 9 6.11 1.47 0.67^2.80
Lymphatic & Hematopoietic Cancer 27 34.95 0.77 0.51^1.12
Non-Hodgkin’s lymphoma 6 12.37 0.49 0.18^1.06
Leukemia 15 13.22 1.13 0.63^1.87
Diabetes mellitus 35 38.79 0.90 0.63^1.26
Blood and blood-forming organ disease 9 6.50 1.38 0.63^2.63
Mental & psych disorders 38 26.82 1.42 1.00^1.95
Alcoholism 23 9.21 2.50 1.58^3.75
Other mental disorders 15 17.60 0.85 0.48^1.41
Nervous system disorders 19 35.80 0.53 0.32^0.83
Heart disease 521 520.14 1.00 0.92^1.09
Ischemic heart disease 414 403.99 1.02 0.93^1.13
Chronic disease of endocardium 5 7.74 0.65 0.21^1.51
Hypertension with heart disease 18 24.34 0.74 0.44^1.17
Other heart disease 82 78.36 1.05 0.83^1.30
Other circulatory system disease 101 142.84 0.71 0.58^0.86
Hypertension without heart disease 14 11.64 1.20 0.66^2.02
Cerebrovascular disease (stroke) 60 94.76 0.63 0.48^0.82
Diseases of the arteries, veins, pulmonary circulation 27 36.45 0.74 0.49^1.08
Respiratory system disease 120 132.60 0.90 0.75^1.08
Pneumonia 36 42.94 0.84 0.59^1.16
Chronic obstructive pulmonary disorder 54 63.15 0.86 0.64^1.12
Pneumoconiosis & other respiratory diseases 27 22.58 1.20 0.79^1.74
Digestive system disease 60 66.48 0.90 0.69^1.16
Genital-urinary system disease 33 34.94 0.94 0.65^1.33
Symptoms and ill-defined conditions 9 20.34 0.44 0.20^0.84
Accidents 93 77.63 1.20 0.97^1.47
Transportation accidents 24 35.05 0.68 0.44^1.02
Accidental poisoning 5 4.05 1.24 0.40^2.88
Accidental falls 13 11.15 1.17 0.62^1.99
Other accidents 50 25.35 1.97 1.46^2.60
(Continued )
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septum, ulcerated nasal septum, perforated nasal septum,
ulcerated skin, irritated skin, dermatitis, burn, and conjuncti-
vitis was found using separate logistic regression models. The
data are not shown. The risk of lung cancer death increased
with frequency of nasal irritations per individual and differed
with type of nasal irritation (Table V).
DISCUSSION
The current report adds more than 20,000 person-years
of observation to the study of the Baltimore chromium
production workers. Death from lung cancer remains
significantly elevated. Deaths from other types of cancer
TABLEI. (Continued.)
Cause of Death Observed Expected SMR (O/E) 95% CI
Violence 49 42.59 1.15 0.85^1.52
Suicide 23 19.43 1.18 0.75^1.78
Homicide 26 23.14 1.12 0.73^1.65
Other & unspecified causes 54 43.23 1.25 0.94^1.63
CI,Confidence interval; O/E, Observed/Expected; SMR, Standardizedmortality ratio.
aExpected deaths are based on age-, race-, and calendar-year specific rates for the United States
bObserved deaths reported for causes of death with five ormore deaths.
cThe current report includes1,243white, 879 nonwhite, and 232 individuals of unknown race.The averagenumberof years of followup for the cohort is 38.9 (SD¼14.2).The
average number of years of followup for whites, nonwhites, and race unknown is 39.7, 37.2, and 40.7 years, respectively.
TABLE II. Description of Cohort by Cumulative Chromium (VI) Exposure,Cumulative Chromium (III) Exposure,Years ofWork at the Plant,Years of













Calendar year of hire
(19XX)a
Mean (SD)
Total group 0.14 (0.36) 2.01 (5.31) 3.1 (6.5) 38.9 (14.2) 30.2 (7.5) 58(7.7)
Lung cancer
cases
0.23 (0.52) 3.17 (7.25) 4.8 (8.6) 33.8 (10.7) 31.4 (8.0) 56 (6.1)
Noncases 0.13 (0.34) 1.89 (5.06) 2.9 (6.2) 39.4 (14.4) 30.0 (7.5) 58 (7.8)
Median
Total group 0.01 0.11 0.4 39.9 28.6 54
Lung cancer
cases
0.02 0.18 0.5 34.4 29.5 53
Noncases 0.01 0.11 0.4 40.4 28.6 54
Min/max
Total group 0/5.25 0/64.67 0.003/37.8 0.3/61.4 16.9/63.0 50/74
Lung cancer
cases
0/4.09 0/40.70 0.003/34.0 6.4/57.2 20.5/62.6 50/74
Noncases 0/5.25 0/64.70 0.003/37.8 0.3/61.4 16.9/63.0 50/74
25th percentile
Total group 0.001 0.02 0.1 29.4 24.4 51
Lung cancer
cases
0.002 0.02 0.1 27.1 25.1 51
Noncases 0.001 0.01 0.1 30.0 24.2 51
75th percentile
Total group 0.08 1.03 2.1 49.5 34.5 65
Lung cancer
cases
0.20 1.69 4.1 41.0 36.2 57
Noncases 0.07 0.95 1.9 50.4 34.2 65
aXX are the last two digits of the year of hire. For example, 55means that the individual was hired in1955.
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were not elevated. The lung cancer risk was elevated in all
four quartiles compared to the expected based on Maryland
rates and was significantly elevated in the 2nd, 3rd, and 4th
cumulative exposure quartiles.
Considering person-years over the age of 96 as lost to
follow-up had little effect on the estimates. Forty-six of the
2,354 persons in the cohort were found to be over the age of
96 meaning that 280 person-years were not included in the
analysis. The average age of death in the cohort was 65. The
average age of death from lung cancer was also 65.
Despite the significant prevalence of smoking in the
cohort (>80%), cumulative chromium (VI) exposure was
FIGURE1. Time from Date of Employment until Death for the 217 Lung Cancer Deaths Among Chromium Production Workers, Balti-
more, MD, 1950-2011
TABLE III. Observed and Expected Lung Cancer Deaths,Person-Years of Observation, Observed to Expected Ratios, and Cumulative Chromium (VI)




3-years) Metric 20^29 30^39 40^49 50^59 60^69 70^79 80þ
0^0.00149 Observed 0 1 0 14 14 13 3
Expected 0.0275 0.3466 2.2253 7.1421 12.2755 11.3581 7.0446
O/E 0.00 2.89 0.00 1.96 1.14 1.14 0.43
Person-Years 5,545.87 7,672.32 6,468.66 5,392.98 3,942.02 2,376.38 1,351.31
Mean exposure 0.000033 0.000224 0.000424 0.000513 0.000524 0.000522 0.000481
0.0015^0.0089 Observed 0 0 2 10 20 19 3
Expected 0.0023 0.1854 1.7781 6.2058 10.4293 8.8081 3.8269
O/E 0.00 0.00 1.12 1.61 1.92 2.16 0.78
Person-Years 435.22 3,315.10 4,862.83 4,685.27 3,472.45 1,890.98 738.86
Mean exposure 0.0043 0.0043 0.0043 0.0043 0.0041 0.0040 0.0040
0.009^0.0769 Observed 0 0 3 12 20 9 6
Expected 0.0029 0.1938 1.8068 6.4178 11.0683 9.2413 3.6495
O/E 0.00 0.00 1.66 1.87 1.81 0.97 1.64
Person-Years 564.68 3,682.89 5,075.77 4,995.92 3,751.88 1,975.74 708.86
Mean exposure 0.030 0.031 0.030 0.030 0.031 0.031 0.028
0.077^5.25 Observed 0 0 8 12 30 17 1
Expected 0.0010 0.1574 1.6448 6.1926 10.3370 8.0835 2.5588
O/E 0.00 0.00 4.86 1.94 2.90 2.10 0.39
Person-Years 205.54 2,871.27 4,608.52 4,839.11 3,525.14 1,743.25 487.26
Mean exposure 0.199 0.297 0.391 0.465 0.515 0.572 0.624
O/E,Observed/Expected.
aExpected deaths are based on age-, race-, and calendar-year specific rates forMaryland.
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still a significant predictor of lung cancer risk. Only four lung
cancer cases did not smoke, and the smoking status of 11 lung
cancer cases was unknown. When the O/E analysis was
limited to smokers, the O/E for each cumulative chromium
(VI) exposure quartile increased, and there was a monotonic
increase in the SMR across quartiles. This may suggest an
interaction of chromium (VI) exposure and smoking with
respect to lung cancer risk; however, the limited number of
lung cancer cases who did not smoke (N¼ 4) did not permit
further statistical evaluation.
The mean length of time from the date of first
employment until the date of lung cancer death was 33.8
(SD¼ 10.7) years, suggesting a fairly long latency. The
range was 6.4–57.2 years. Enterline [1974] stated that
the risk of lung cancer death was highest shortly after
active employment in the chromate production industry
suggesting a “short latency period probably as the result
of exposure to a very potent carcinogen.” To be included
in the cohort described by Enterline [1974]; workers had
to have been employed “sufficiently long” at any one of
three chromium production plants during the period
January 1, 1937 to December 31, 1940 [Taylor, 1966].
Exposure in the Taylor [1966] cohort, on which the
observations by Enterline [1974] are based, likely reflect
much higher cumulative exposures than in the present
cohort. The Baltimore plant built a new mill and roast
department in 1950 using what were considered state of
the art industrial hygiene practices. Furthermore, unlike the
Taylor [1966] cohort, short term workers (<90 days
employment) were included in the present cohort. The
difference in average cumulative exposure between the
Taylor [1966] cohort and the present cohort likely explains
the difference in what Enterline [1974] describes as a short
latency period vs. the relatively long mean latency in the
present cohort.
Cumulative chromium (VI) exposure was not a
statistically significant predictor of lung cancer (P¼ 0.143)
in the proportional hazards model which included cumula-
tive chromium (III) and smoking as covariates. However,
cumulative chromium (VI) exposure was a statistically
significant predictor in the proportional hazards model with
smoking and duration of employment. Given the strong
correlation between cumulative chromium (VI) and cumula-
tive chromium (III) exposure, the lack of statistical
significance of cumulative chromium (VI) in the model
with smoking and chromium (III) was not surprising.
TABLE IV. Lung Cancer Observed and Expecteda Deaths, Person-Years of Observation, and Observed-to-Expected Ratios by Race for the Four
Exposure Quartiles for Chromium ProductionWorkers,Baltimore,MD,1950-2011
Cumulative Exposure (mg CrO3/m
3-years) O E O/E Person- Years 95% CI
White
0^0.00149 26 26.14 0.99 18,966 0.65^1.46
0.0015^0.0089 35 16.82 2.08 9,101 1.45^2.89
0.009^0.0768 29 17.90 1.62 20,512 1.08^2.33
0.077^5.25 31 17.13 1.81 499 1.23^2.57
Non-white
0^0.00149 15 12.06 1.24 10,013 0.70^2.05
0.0015^0.0089 17 13.39 1.27 6,968 0.74^2.03
0.009^0.0768 18 13.58 1.33 7,667 0.79^2.10
0.077^5.25 36 13.29 2.71 8,024 1.90^3.75
Unknown Race
0-0.00149 4 4.52 0.89 3,770 0.24^2.27
0.0015^0.0089 2 3.64 0.55 2,832 0.06^1.98
0.009^0.0768 3 3.18 0.95 2,238 0.19^2.76
0.077^5.25 1 0.67 1.51 596 0.02^8.30
Total
0^0.00149 45 42.72b 1.05 32,750 0.77^1.41
0.0015^0.0089 54 33.85b 1.60 18,901 1.20^2.08
0.009^0.0768 50 34.66b 1.44 30,416 1.07^1.90
0.077^5.25 68 31.09b 2.19c 9,119 1.70^2.77
E,Expected; O,Observed; O/E, Observed/Expected.
aExpected deaths are based on age-, race-, and calendar-year specific rates forMaryland.
bWeighted E; Expected counts for unknown racewere calculatedby theweighted average of the expected counts for whites andnonwhites basedon the ratio of whites and
nonwhites in the population.
cTrend testP< 0.001.
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Eight clinically diagnosed signs of irritation were
significantly (P> 0.05) associated with lung cancer death.
The odds ratio for lung cancer death increased with
frequency of irritation per individual. This was true for the
four types of nasal irritation and all other forms of irritation
except perforated ear. These findings may simply indicate
that irritation is a marker of exposure; alternatively they may
indicate that irritation is a mechanism for chromium (VI)-
induced lung cancer. Inflammation is recognized as having a
role in tumor promotion in general [Coussens and Werb,
2002; Mantovani et al., 2008], and it has specifically been
recognized as having a role with respect to lung cancer [Azad
et al., 2008; Engels, 2008; Lee et al., 2008].
The Occupational Safety and Health Administration’s
(OSHA) Permissible Exposure Level (PEL) for chromium
(VI) is 5mg/m3 as an 8-hour time weighted average [OSHA,
2006]. OSHA assumes that a working lifetime is 45 years. If
one worked 45 years and was exposed to an 8-hour time
weighted average of 5mg/m3, the cumulative exposure would
be 225mg/m3-work years. That exposure would fall in the
highest exposure quartile in the current study. The NIOSH
REL for chromium (VI) is 0.2mg/m3 as an 8-hour time-
weighted average [NIOSH, 2013b]. Assuming a 45 year
working lifetime at the REL, the cumulative exposure would
fall in the 3rd exposure quartile of the current study.
Other studies have also evaluated lung cancer risk by
cumulative chromium (VI) exposure [Mancuso, 1975; Gerin
et al., 1993; Mancuso, 1997; Luippold et al., 2003]. These
studies, however, do not have the historic and prolific exposure
data, the amount of information on smoking, the number of
lung cancer deaths, or the person-years of observation of the
current study. Furthermore, the present study evaluates lung
cancer risk at much lower cumulative exposures than the
aforementioned studies and is the only study to evaluate the
relationship of irritation and lung cancer risk.
ACKNOWLEDGMENTS
The authors wish to thank Dr. Paul Pinsky of the
National Cancer Institute for his expert advice on the
analysis. The authors also wish to thank Ms. Emily Ryan, a
student in the Environmental and Occupational Health
Department of the George Washington University Milken
Institute School of Public Health for her assistance in the
preparation of the manuscript. Funding for this study was
partially provided by the United States Environmental
Protection Agency, PO EP06H000522.
REFERENCES
Akaike, H. 1973. Information theory and an extension of the maximum
likelihood principle. In Proc. 2nd Int. Symp. Info. Theory, Ed. B. N.
Petrov and F. Csaki, pp 267-81. Budapest: Akademia Kiado.




Point Estimate 95%Wald Confidence Limits
Irritated Nasal Septum
None (referent) 1.000 ç
1or 2 from dispensary record, physical exam or hospital 1.218 0.826, 1.795
3 or more from dispensary record, physical exam or hospital 1.597a 1.134, 2.250
Ulcerated Nasal Septum
None 1.000 ç
1or 2 from dispensary record, physical exam or hospital 1.078 0.681, 1.707
3 or more from dispensary record, physical exam or hospital 1.715b 1.247, 2.361
Perforated Nasal Septum
None (referent) 1.000 ç
1or 2 from dispensary record, physical exam or hospital 1.572 1.004, 2.463
1or more from compensation report 2.293 1.480, 3.552
3 or more from dispensary record, physical exam or hospital 2.656b 1.148, 6.145
Bleeding Nasal Septum
None (referent) 1.000 ç
1or 2 from dispensary record, physical exam or hospital 0.876 0.536, 1.433
3 or more from dispensary record, physical exam or hospital 1.432 0.639, 3.210
aP for trend<0.01.
bP for trend<0.001.
912 Gibb et al.
Armitage P 1955. Tests for linear trends in proportions and frequencies.
Biometrics 11:375–386.
Azad N, Rojanasakul Y, Vallyathan V. 2008. Inflammation and lung
cancer: Roles of reactive oxygen/nitrogen species. J Toxicol and Env
Heal B 11((1)):1–15.
Baetjer AM 1950. Pulmonary carcinoma in chromate workers. II.
Incidence on basis of hospital records. AMA Arch Indust Hyg and
Occup Med 2:505–516.
Breslow N, Lubin J, Marek P, Langholz B. 1983. Multiplicative models
and cohort analyses. J Am Stat Assoc 78:1–12.
Cochran W G 1954. Some methods of strengthening the common Х2
tests. Biometrics 10:417–451.
Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature
420:860–867.
Engels EA 2008. Inflammation in the development of lung cancer:
Epidemiological evidence. Expert Rev Anticancer Ther 8(4):605–615.
Enterline P 1974. Respiratory cancer among chromate workers. J Occup
Med 16(8):523–526.
Gerin M, Fletcher AC, Gray C, Winkelmann R, Boffetta P, Simonato L.
1993. Development and use of a welding process exposure matrix in a
historical prospective study of lung cancer risk in European welders. Int
J Epidemiol 22(Suppl 2):S22–S28.
Gibb HJ, Lees PSJ, Pinsky PF, Rooney BC. 2000a. Lung cancer among
workers in chromium chemical production. Am J IndMed 38(2):115–126.
Gibb HJ, Lees PSJ, Pinsky PF, Rooney BC. 2000b. Clinical findings of
irritation among chromium chemical production workers. Am J Ind
Med 38(2):127–131.
Hayes RB, Lilienfeld AM, Snell LM. 1979. Mortality in chromium
chemical production workers: A prospective study. Int J Epidemiol
8(4):365–373.
IARC. 1990. Monographs on the evaluation of carcinogenic risks to
humans: chromium, nickel, and welding. Volume 49. International
Agency for Research on Cancer, Lyons, France.
IARC. 2012. Arsenic, metals, fibres, and dusts. Volume 100C. A review
of human carcinogens. IARC monographs on the evaluation of
carcinogenic risks to humans. International Agency for Research on
Cancer, Lyons, France.
Lee JM, Yanagawa J, Peebles KA, et al. 2008. Inflammation in lung
carcinogenesis: new targets for lung cancer chemoprevention and
treatment. Cr Rev Oncol-Hem 66(3):208–217.
Luippold RS, Mundt KA, Austin RP, Liebig E, Crump C, Crump K,
Proctor D. 2003. Lung cancer mortality among chromate production
workers. Occup Environm Med 60:451–457.
Mancuso, TF. 1975. Consideration of chromium as an industrial
carcinogen.
International Conference on Heavy Metals in the Environment,
Toronto, Ontario, Canada, October 27–31. pp. 343-356.
Mancuso TF 1997. Chromium as an industrial carcinogen: Part I. Am J
Ind Med 31:129–139.
Machle W, Gregorius F. 1948. Cancer of the respiratory system in
the U.S. chromate-producing industry. Pub Health Rep 63:1114–1127.
Mancuso TF, Hueper WC. 1951. Occupational cancer and other health
hazards in a chromate plant: a medical appraisal. I. Lung cancer in
chromate workers. Indust Med and Surg 20:358–363.
Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related
inflammation. Nature 454:436–444.
National Center for Health Statistics. 2014. The National Death Index.
Hyattsville, MD: National Center for Health Statistics; 2014. (http://
www.cdc.gov/nchs/ndi.htm). (Accessed May 20, 2015).
NIOSH. 2013a. National Institute for Occupational Safety and Health
(NIOSH). Life table analysis system, LTAS.NET ver. 3.0.1. Wash-
ington, DC: NIOSH (http://www.cdc.gov/niosh/ltas/). (Accessed
May 20, 2015).
NIOSH. 2013b National Institute for Occupational Safety and Health
Criteria for a Recommended Standard: Occupational Exposure to
Chromium (VI). Washington, DC: National Institute for Occupational
Safety and Health (DHHS publication no. 2013-128).
OSHA. 2006. Occupational Safety and Health Administration Final
Rule. “Occupational Exposure to Chromium (VI).” Federal Register 71,
no. 39 (February 28, 2006): 10099-10385. (http://www.osha.gov/pls/
oshaweb/owadisp.show_document?p_id=18599&p_table=federal_-
register). (Accessed May 20, 2015).
Park RM, Bena JF, Stayner LT, Smith RJ, Gibb HJ, Lees PSJ. 2004.
Chromium (VI) and lung cancer in the chromate industry: A
quantitative risk assessment. Risk Anal 24(5):1099–1108.
U.S. Public Health Service. 1951. Health of workers in chromate
producing industry - a study. Public Health Service Publication No. 192.
Rothman KJ, Boice JD Jr. 1979. Epidemiologic Analysis with a
Programmable Calculator. Washington, DC: US Government Printing
Office. 142 p.
SAS Institute Inc. 2009. SAS statistical software, version 9.2. Cary, NC:
SAS Institute Inc., 2009.
Taylor F 1966. The relationship of mortality and duration of
employment as reflected by a cohort of chromate workers. Am J
Public Health 56(2):218–229.
WHO. 2013. Inorganic chromium (VI) compounds. Concise Interna-
tional Chemical Assessment Document 78. World Health Organization,
Geneva.
Dr. Herman Gibb has served as an expert witness in tort cases involving hexavalent
chromium.
Dr. Gibb prepared the manuscript and directed the analysis. Dr. Lees obtained and
analyzed vital status from the National Death Index and reviewed and commented on
the manuscript. Ms. Wang and Ms. O’Leary conducted statistical analyses and re-
viewed and commented on the manuscript. The enclosed manuscript is an original
work. It has not been published previously in whole or in part and is not under consid-
eration for publication elsewhere. All authors have read the manuscript and agree that
the work is prepared for journal submission. All authors accept responsibility for the
contents of the enclosed manuscript.
Chromium Production Workers, Baltimore, MD, 1950-2011 913
